Nadroparin clinical trials LMWH

LMF CY216 - LMF CY 216 - LMF CY-216 - CY216 - CY-216 - CY 216 - Fraxiparine - Fraxiparin - Nadroparine

Acute coronary syndrome

All type of patients:  2 trials  - FRAXIS (14 days) - FRAXIS (6days)

Pulmonary embolism

3 trials  - Prandoni sub-group - Thery - European multicentre study

Superficial thrombophlebitis

3 trials  - Vesalio - Titon (nadroparin 0.6ml vs naproxen) - Titon (nadroparin 61.5 IU anti-Xa/kg vs naproxen)

Thrombosis prevention

Abdominal surgery:  1 trials  - EFS

Arthroscopy:  2 trials  - KANT (14 days) - KANT (7 days)

Elective hip replacement:  1 trials  - Yoo

General surgery:  7 trials  - Eurin - Barbui - Dahan - EFS - Kakkar and Murray - Balas [40] - Marassi [41]

Hip Fracture:  1 trials  - Sourmelis

Medical patients:  3 trials  - Mahe - Fraisse - Bergmann

Neurosurgery:  1 trials  - Nurmohamed

Orthopedic surgery:  3 trials  - NPHDO - Yoo - Sourmelis

Patients with immobilization of the lower extremities:  2 trials  - Kujath - PROTECT (nadroparin)

Venous thrombosis

All type of patients:  6 trials  - Lopez-Beret - Lopaciuk - Charbonnier - Lopaciuk et al - Prandoni et al - Collaborative European Multicentre

Patients with cancer:  1 trials  - Lopez Beret